Prosthetic Device with Antibiotic-Eluting Beads

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current prosthetic devices implanted in the human body are prone to infections, with one-stage treatment methods showing a higher risk of reinfection due to inadequate antibiotic delivery, as existing antibiotic-loaded gels are ineffective against bacteria within the bone or joint site.

Innovation Solution

A prosthetic device with a structure featuring a tubular wall, inner cavity, and strategically placed holes or ports to house a filler material that absorbs and elutes antibiotics, ensuring prolonged exposure and effective delivery of antibiotics to the implant site, thereby preventing or treating infections.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Object-affected harmful factors

If antibiotic-loaded gels are applied on the outer surface of a prosthesis, then bacteria present in the outside environment are prevented from settling on the prosthesis, but the gels are ineffective against bacteria within the bone or joint site due to overly reduced contact time

Engineering Contradiction:
Improveprevention of bacterial settlement on prosthesis surfaceVSAvoideffectiveness against bacteria within bone or joint site
Core Design Contradiction:
Object-affected harmful factorsVSReliability

Solution Approach 1:

The patent embeds a reservoir containing antibiotic-eluting beads inside the prosthesis structure. The reservoir is nested within the prosthesis body, allowing the antibiotic delivery system to be integrated within the implant rather than applied externally. This enables prolonged antibiotic release directly at the implant site, effectively treating bacteria within the bone or joint site while maintaining the prosthesis structural integrity.

Inventive Principle:
Principle #7Nested doll (Nesting)

Solution Approach 2:

The patent introduces antibiotic-eluting beads as an intermediary substance between the antibiotic reservoir and the surrounding tissue. These beads absorb antibiotic solution and gradually elute it into the surrounding bone or joint site, extending the contact time and ensuring effective antibiotic delivery to bacteria within the implant site. The beads act as a controlled release mechanism, mediating between the stored antibiotic and the target bacteria.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Device complexity

If a one-stage treatment is used where the new prosthesis is immediately inserted after cleaning the surgical site, then the treatment procedure is simplified, but the risk of reinfection increases due to inadequate antibiotic delivery

Engineering Contradiction:
Improvesimplicity of treatment procedureVSAvoidrisk of reinfection
Core Design Contradiction:
Device complexityVSReliability

Solution Approach 1:

The patent incorporates antibiotic-loaded beads into the prosthesis before implantation, performing the antibiotic loading action in advance during the manufacturing or preparation phase. This preliminary action ensures that the prosthesis is pre-equipped with a sustained-release antibiotic system, eliminating the need for separate antibiotic application steps during surgery while maintaining effective infection prevention and treatment capabilities.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent combines the prosthesis structure with the antibiotic delivery system into a single integrated device. The reservoir containing antibiotic-eluting beads is merged with the prosthesis body, creating a unified implant that simultaneously provides mechanical support and sustained antibiotic release. This merging allows the one-stage treatment to maintain both procedural simplicity and infection prevention reliability.

Inventive Principle:
Principle #5Merging (Combining)

3Ease of repair

If the prosthesis is inserted without bone cement, then it is more easily removable in case of new infection, but the use of bone cement is substantially required when bone conditions are compromised

Engineering Contradiction:
Improveremovability of prosthesisVSAvoidfixation strength when bone conditions are compromised
Core Design Contradiction:
Ease of repairVSStrength

Solution Approach 1:

The patent changes the fixation method from mechanical interlocking with bone cement to biological integration through porous coating. The porous coating on the prosthesis surface allows bone ingrowth, creating a strong biological bond that replaces the need for bone cement. This parameter change in the fixation mechanism maintains ease of removal (by disrupting bone ingrowth rather than cement bond) while providing adequate fixation strength even in compromised bone conditions through enhanced osseointegration.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The prosthetic device effectively prevents or treats infections by providing sustained antibiotic release, reducing the risk of reinfection and maintaining mechanical properties comparable to conventional prostheses.

Implementation Method 1

The filler material (7) has a capillary capacity and it is capable of absorbing a solution containing an antibiotic or medical substance

Methodology Applied
Scientific EffectCapillary action: Capillary Action

Implementation Method 2

such prosthetic device is capable of eluting or diffusing an antibiotic substance in order to prevent the onset of an infection or cure an infection underway

Methodology Applied
Scientific EffectDiffusion: Diffusion

Data Source

PatentUS20240307186A1Prosthetic device with antibiotics
Publication Date: 2024.09.19 TECRES SPA
  • US20240307186A1 patent drawing
  • US20240307186A1 patent drawing
  • US20240307186A1 patent drawing

AI summary

Prosthetic device suitable for being implanted in a bone or joint site of the human body, including a prosthetic body, wherein the prosthetic device includes or can be added with antibiotic or a medical substance.